Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease John-Paul Carter1, Aroon D Hingorani1, John Wilkins2, http://orcid.org/0000-0003-1327-0424Amand Floriaan Schmidt3 1 Centre for Clinical Pharmacology and Therapeutics, Institute of Health Informatics, University College London, London, UK 2 The Department of Medicine (Cardiology) and the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago,...